Similar articles

• Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.

  Bianchi S, Bigazzi R, Campese VM. Bianchi S, et al. Kidney Int. 2006 Dec;70(12):2116-23. doi: 10.1038/sj.ki.5001854. Epub 2006 Oct 11. Kidney Int. 2006. PMID: 17035949 Clinical Trial.
• Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function.

  Slagman MC, Sinkeler SJ, Hemmelder MH, Waanders F, Vogt L, Kluin-Nelemans HC, Navis G, Laverman GD. Slagman MC, et al. Nephrol Dial Transplant. 2010 Oct;25(10):3256-60. doi: 10.1093/ndt/gfq149. Epub 2010 Mar 25. Nephrol Dial Transplant. 2010. PMID: 20339099 Clinical Trial.
• [Renal effects of combined anti-hypertensive treatments].

  Gallieni M, Olivi L, Mezzina N, Cozzolino M, Cusi D. Gallieni M, et al. Recenti Prog Med. 2010 Feb;101(2):70-7. Recenti Prog Med. 2010. PMID: 20433005 Review. Italian.
• Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.

  Berl T. Berl T. Nephrol Dial Transplant. 2008 Aug;23(8):2443-7. doi: 10.1093/ndt/gfn239. Epub 2008 May 8. Nephrol Dial Transplant. 2008. PMID: 18467376 Review. No abstract available.
• Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.

  Seeman T, Pohl M, Misselwitz J, John U. Seeman T, et al. Kidney Blood Press Res. 2009;32(6):440-4. doi: 10.1159/000266478. Epub 2009 Dec 17. Kidney Blood Press Res. 2009. PMID: 20016211